NASDAQ:AWH Aspira Women's Health (AWH) Stock Price, News & Analysis → Why June 30 Will Be the Tipping Point for AI (From Banyan Hill Publishing) (Ad) Free AWH Stock Alerts $2.10 +0.03 (+1.45%) (As of 09:32 AM ET) Add Compare Share Share Today's Range$2.10▼$2.1050-Day Range$2.07▼$3.5352-Week Range$1.96▼$6.75Volume575 shsAverage Volume31,901 shsMarket Capitalization$26.15 millionP/E RatioN/ADividend YieldN/APrice Target$4.45 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Aspira Women's Health alerts: Email Address Aspira Women's Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside115.0% Upside$4.45 Price TargetShort InterestHealthy2.18% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.96Based on 3 Articles This WeekInsider TradingAcquiring Shares$22,973 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.30) to ($0.85) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.18 out of 5 starsMedical Sector506th out of 905 stocksDiagnostic Substances Industry8th out of 14 stocks 3.3 Analyst's Opinion Consensus RatingAspira Women's Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAspira Women's Health has only been the subject of 1 research reports in the past 90 days.Read more about Aspira Women's Health's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.18% of the float of Aspira Women's Health has been sold short.Short Interest Ratio / Days to CoverAspira Women's Health has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Aspira Women's Health has recently decreased by 0.18%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAspira Women's Health does not currently pay a dividend.Dividend GrowthAspira Women's Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AWH. Previous Next 3.3 News and Social Media Coverage News SentimentAspira Women's Health has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Aspira Women's Health this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Aspira Women's Health to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aspira Women's Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $22,973.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 4.30% of the stock of Aspira Women's Health is held by insiders.Percentage Held by InstitutionsOnly 12.19% of the stock of Aspira Women's Health is held by institutions.Read more about Aspira Women's Health's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aspira Women's Health are expected to grow in the coming year, from ($1.30) to ($0.85) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aspira Women's Health is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aspira Women's Health is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Aspira Women's Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingWhy June 30 Will Be the Tipping Point for AIAI is already replacing workers in warehouses. It’s spreading like lightning in the software, legal and engineering industries… It’s now estimated at least 300 million jobs worldwide are in AI’s crosshairs.Click here for details. About Aspira Women's Health Stock (NASDAQ:AWH)Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz for the generation of a multi-omic, non-invasive diagnostic aid to identify endometriosis based on circulating miRNAs and proteins; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.Read More AWH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AWH Stock News HeadlinesJune 5 at 5:24 AM | insidertrades.comNicole Sandford Buys 9,493 Shares of Aspira Women's Health Inc. (NASDAQ:AWH) StockJune 3, 2024 | americanbankingnews.comAspira Women's Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.comMay 28, 2024 | americanbankingnews.comAspira Women's Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.comMay 16, 2024 | msn.comAspira Women’s Health Inc. (NASDAQ:AWH) Q1 2024 Earnings Call TranscriptMay 16, 2024 | finance.yahoo.comAspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21May 16, 2024 | globenewswire.comAspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21May 16, 2024 | finance.yahoo.comAspira Womens Health Inc (AWH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 15, 2024 | finanznachrichten.deAspira Women's Health Inc.: Aspira Women's Health Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comAspira Women’s Health Reports First Quarter 2024 Financial ResultsMay 15, 2024 | globenewswire.comAspira Women's Health Reports First Quarter 2024 Financial ResultsMay 8, 2024 | finance.yahoo.comUPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15May 8, 2024 | globenewswire.comUPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15May 8, 2024 | finance.yahoo.comAspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15May 8, 2024 | globenewswire.comAspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15May 7, 2024 | finance.yahoo.comAspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed ManuscriptsMay 2, 2024 | finance.yahoo.comAspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatchApril 9, 2024 | globenewswire.comAspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in CaliforniaApril 5, 2024 | msn.comAspira Women's Health files to sell 1.57M shares for holdersApril 3, 2024 | benzinga.comAspira Womens Health Stock (NASDAQ:AWH), Analyst Ratings, Price Targets, PredictionsApril 1, 2024 | msn.comAspira Women’s Health Inc. (NASDAQ:AWH) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comAspira Women's Health Inc. (AWH) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | msn.comAspira Women’s Health GAAP EPS of -$0.30 beats by $0.15, revenue of $2.13M misses by $0.42MMarch 28, 2024 | finanznachrichten.deAspira Women's Health Inc.: Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | finance.yahoo.comAspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | globenewswire.comAspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial ResultsSee More Headlines Receive AWH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspira Women's Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/21/2024Today6/07/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:AWH CUSIPN/A CIK926617 Webwww.aspirawh.com Phone512-519-0400Fax512-439-6908Employees64Year FoundedN/APrice Target and Rating Average Stock Price Target$4.45 High Stock Price Target$5.60 Low Stock Price Target$3.30 Potential Upside/Downside+111.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,690,000.00 Net Margins-163.95% Pretax Margin-163.95% Return on Equity-1,099.32% Return on Assets-197.81% Debt Debt-to-Equity RatioN/A Current Ratio1.16 Quick Ratio1.11 Sales & Book Value Annual Sales$9.15 million Price / Sales2.86 Cash FlowN/A Price / Cash FlowN/A Book Value($0.23) per share Price / Book-9.13Miscellaneous Outstanding Shares12,450,000Free Float11,915,000Market Cap$26.15 million OptionableNo Data Beta1.50 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Sandra Milligan J.D. (Age 60)M.D., President Ms. Michelle SniderSenior Vice President of Commercial Strategy & OperationsKey CompetitorsAlpha TeknovaNASDAQ:TKNOVolitionRxNYSE:VNRXARCA biopharmaNASDAQ:ABIOImmuCellNASDAQ:ICCCOncoCyteNASDAQ:OCXView All CompetitorsInsiders & InstitutionsNicole SandfordBought 9,493 shares on 5/31/2024Total: $22,973.06 ($2.42/share)B. Riley Wealth Advisors Inc.Sold 53,997 shares on 5/16/2024Ownership: 1.016%B. Riley Wealth Advisors Inc.Bought 53,997 shares on 3/15/2024Ownership: 1.735%Nicole SandfordBought 5,000 shares on 12/6/2023Total: $16,800.00 ($3.36/share)Minh Hoang MerchantSold 980 sharesTotal: $3,302.60 ($3.37/share)View All Insider TransactionsView All Institutional Transactions AWH Stock Analysis - Frequently Asked Questions Should I buy or sell Aspira Women's Health stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aspira Women's Health in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AWH shares. View AWH analyst ratings or view top-rated stocks. What is Aspira Women's Health's stock price target for 2024? 2 equities research analysts have issued twelve-month price targets for Aspira Women's Health's shares. Their AWH share price targets range from $3.30 to $5.60. On average, they predict the company's share price to reach $4.45 in the next year. This suggests a possible upside of 115.0% from the stock's current price. View analysts price targets for AWH or view top-rated stocks among Wall Street analysts. How have AWH shares performed in 2024? Aspira Women's Health's stock was trading at $4.08 at the beginning of 2024. Since then, AWH stock has decreased by 49.3% and is now trading at $2.07. View the best growth stocks for 2024 here. When is Aspira Women's Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our AWH earnings forecast. How were Aspira Women's Health's earnings last quarter? Aspira Women's Health Inc. (NASDAQ:AWH) released its earnings results on Tuesday, May, 21st. The company reported ($0.39) earnings per share for the quarter, missing analysts' consensus estimates of ($0.36) by $0.03. The firm earned $2.15 million during the quarter, compared to analysts' expectations of $2.10 million. Aspira Women's Health had a negative net margin of 163.95% and a negative trailing twelve-month return on equity of 1,099.32%. During the same quarter in the prior year, the firm posted ($10.94) EPS. When did Aspira Women's Health's stock split? Aspira Women's Health shares reverse split before market open on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What is Scott A. Carmilani's approval rating as Aspira Women's Health's CEO? 33 employees have rated Aspira Women's Health Chief Executive Officer Scott A. Carmilani on Glassdoor.com. Scott A. Carmilani has an approval rating of 92% among the company's employees. This puts Scott A. Carmilani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 97.0% of employees surveyed would recommend working at Aspira Women's Health to a friend. What other stocks do shareholders of Aspira Women's Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aspira Women's Health investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and Who are Aspira Women's Health's major shareholders? Aspira Women's Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include B. Riley Wealth Advisors Inc. (1.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Jack W Schuler, Minh Hoang Merchant, Nicole Sandford, Ryan Thinh Phan, Torsten Hombeck, Valerie Barber Palmieri and Veronica Gh Jordan. View institutional ownership trends. How do I buy shares of Aspira Women's Health? Shares of AWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AWH) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspira Women's Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspira Women's Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.